Review of intervention studies on depression in persons with multiple sclerosis

Issues in Mental Health Nursing

Volumn 28, Issue 5, 2007, Pages 511-531

  Walker, I Diane ^a   Gonzalez, Elizabeth W ^b  

^a Griswold Special Care   (United States)

^b DREXEL UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADAPTIVE BEHAVIOR; ATTITUDE TO HEALTH; COGNITIVE THERAPY; DEPRESSION; EVIDENCE BASED MEDICINE; FEMALE; GROUP THERAPY; HOSPITALIZATION; HUMAN; KINESIOTHERAPY; MALE; METHODOLOGY; MULTIPLE SCLEROSIS; MUSIC THERAPY; PREVALENCE; PSYCHOLOGICAL ASPECT; QUALITY OF LIFE; REVIEW; SELF HELP; TREATMENT OUTCOME; YOGA;

ADAPTATION, PSYCHOLOGICAL; ATTITUDE TO HEALTH; COGNITIVE THERAPY; DEPRESSIVE DISORDER; EVIDENCE-BASED MEDICINE; EXERCISE THERAPY; FEMALE; HUMANS; MALE; MULTIPLE SCLEROSIS; MUSIC THERAPY; PREVALENCE; PSYCHOTHERAPY, GROUP; QUALITY OF LIFE; RESEARCH DESIGN; SELF-HELP GROUPS; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME; YOGA;

EID: 34547350002     PISSN: 01612840     EISSN: 10964673     Source Type: Journal    
DOI: 10.1080/01612840701344480     Document Type: Review

References (76)

1. Aikens, J., Fischer, J., Namey, M., & Ridick, R. (1997). A replicated prospective investigation of life stress, coping, and depressive symptoms in multiple sclerosis. Journal of Behavioral Medicine, 20, 433-445.
2. Alexander, L., LaRosa, J., Bader, H., & Garfield, S. (2004). New dimensions in women's health (3rd ed.). Boston: Jones and Bartlett.
3. Andersen, E., Malmgren, J., Carter, W., & Patrick, D. (1994). Screening for depression in well older adults: Evaluation of a short form of the CES-D (Center for Epidemiologic Studies Depression Scale). American Journal of Preventive Medicine, 10, 77-84.
4. Anderson, P., & Goodkin, D. (1996). Current pharmacologic treatment of multiple sclerosis symptoms. Western Journal of Medicine, 165, 313-317.
5. Beck, A., & Hautzinger, M. (1995). Beck-depression-lnventar (BDI). Gottingen: Hogrefe.
6. Beck, A., Steer, R., & Brown, G. (1996). Beck Depression Inventory Manual (2nd ed.). San Antonio, TX: Psychological Corporation.
7. Beck, A., Ward, C., Mendelson, M., Mock, J., & Erbaugh, J. (1961). An inventory for measuring depression. Archives of General Psychiatry, 4, 561-571.
8. Berger, M. (1952). The relationship between expressed acceptance of self and expressed acceptance of others. Journal of Abnormal Psychology, 47, 778-782.
9. Caine, E., & Schwid, S. (2002). Multiple sclerosis, depression, and the risk of suicide. Neurology, 59, 662-663.
10. Chwastiak, L., Ehed, D., Gibbons, L., Sullivan, M., Bowen, J., & Kraft, G. (2002). Depressive symptoms and severity of illness in multiple sclerosis: Epidemiologic study of a large community sample. American Journal of Psychiatry, 759(11), 1862-1868.
11. Classen, C., Butler, L., Koopman, C., Miller, E., DiMiceli, C. et al. (2001). Supportiveexpressive group therapy and distress in patients with metastatic breast cancer: A randomized clinical intervention trial. Archives of General Psychiatry, 58, 494-501.
12. Clement, U., & Lowe, B. (1996). Fragebogen zum Korperbild (FKB-20). Gottinger: Hogrefe.
13. Cohen, J. (1988). Statistical power analysis for the behavioral sciences (3rd ed.). New York: Academic.
14. Cooper, H. M. (1984). The integrative research review: A systematic approach. Beverly Hills, CA. Sage.
15. Cree, B., Khan, O., Bourdette, D., Goodin, D., Cohen, J., Marrie, R., Glidden, D., Weinstock-Guttman, B., Reich, D., Patterson, N., Haines, J., Pericak-Vance, M., DeLoa, C., Okserberg, J., & Hauser, S. (2004). Clinical characteristics of African Americans vs. Caucasian Americans with multiple sclerosis. Neurology, 63, 20392045.
16. Dalton, E., & Heinrichs, R. (2005). Depression in multiple sclerosis: A quantitative review of the evidence. Neuropsychology, 19(2), 152-158.
17. Feinstein, A. (2002). An examination of suicide intent in patients with multiple sclerosis. Neurology, 59, 674-678.
18. First, M., Spitzer, R., Gibbon, M., & Williams, J. (1995). Structured clinical interview for DSM-IVAxis 1 disorders. Washington, DC: American Psychiatric Press.
19. Gold, S., Heesen, C., Schultz, H., & Schulz, K. (2001). Disease specific quality of life instruments in multiple sclerosis: Validation of Hamburg Quality of Life Questionnaire in Multiple Sclerosis (HAQUMAS). Multiple Sclerosis, 7, 119-130.
20. Gold-Spink, E., Sher, T., & Theodos, V. (2000). Uncertainty in illness and optimism in couples with multiple sclerosis. International Journal of Rehabilitation and Health, 5(3), 157-164.
21. Goldman Consensus Group. (2005). The Goldman consensus statement on depression in multiple sclerosis. Multiple Sclerosis, 11, 328-337.
22. Goodkin, D. (1992). The natural history of multiple sclerosis. In R. A. Rudick & D. E. Goodkin (Eds.), Treatment of multiple sclerosis: Trial design, results, and future perspectives (pp. 17-46). New York: Springer-Verlag.
23. Hamilton, M. (1960). A rating scale for depression. Journal of Neurology & Neurosurgical Psychiatry, 23, 56-62.
24. Hart, S., Fonareva, I., Merluzzi, N., & Mohr, D. (2005). Treatment for depression and its relationship to improvement in quality of life and psychological well-being in multiple sclerosis patients. Quality of Life Research, 14, 695-703.
25. Hauser, S., & Goodkin, D. (2001). Multiple Sclerosis and other demyelinating diseases. In E. Braunwald, A. Fauci, K. Isselbacher et al. (Eds.), Harrison's principles of internal medicine (15th ed., pp. 1096-1133). Columbus, OH: McGraw-Hill.
26. Janssens, A., van Doom, P., de Boer, J., Kalkers, N., van der Meche, F., Passchier, L, & Hintzen, R. (2003). Anxiety and depression influence the relation between disability status and quality of life in multiple sclerosis. Multiple Sclerosis, 9, 397-403.
27. Joffe, R., Lippert, G., Gray, T., Sawa, G., & Horvath, Z. (1987). Mood disorder and multiple sclerosis. Archives of Neurology, 44, 376-378.
28. Joseph, S., & Linley, P. (2005) Positive adjustment to threatening events: An organismic valuing theory of growth through adversity. Review of General Psychology, 9(3), 262-280.
29. Joy, J., & Johnson, R. (2001). Clinical and biological features in multiple sclerosis: Current status and strategies for the future. Washington, DC: National Academy Press.
30. Katon, W. (1996) The impact of major depression on chronic medical illness. General Hospital Psychiatry, 18, 215-219.
31. Kroencke, D., Denney, D., & Lynch, S. (2001) Depression during exacerbations in multiple sclerosis: The importance of uncertainty. Multiple Sclerosis, 7, 237-242.
32. Kurtzke, J. (1983). Rating neurologic impairment in multiple sclerosis: An expanded disability status scale. Neurology, 33, 1444-1442.
33. Lynch, S., Kroencke, D., & Denney, D. (2001) The relationship between disability and depression in multiple sclerosis: The role of uncertainty, coping and hope. Multiple Sclerosis, 7, 411-416.
34. McNair, D., Lorr, M., & Droppleman, L. (1981). Manual for the profile of mood states. San Diego: EdITS/Educational and Industrial Testing Service.
35. McNair, D., Lorr, M., & Droppleman, M. (1992). Manual for the profile of mood states. San Diego: EdITS/Educational and Industrial Testing Service.
36. McNulty, K., Livneh, H., & Wilson, L. (2004) Perceived uncertainty, spiritual well-being, and psychosocial adaptation in individuals with multiple sclerosis. Rehabilitation Psychology, 49(2), 91-99.
37. Minden, S., Orav, J., & Reich, P. (1987). Depression in multiple sclerosis. General Hospital Psychiatry, 9, 426-434.
38. Minden, S., & Schiffer, R. (1990). Affective disorders in multiple sclerosis. Review and recommendations for clinical research. Archives of Neurology, 47(1), 98-104.
39. Mohr, D., Boudewyn, A., Goodkin, D., Bostrom, A., & Epstein, L. (2001). Comparative outcomes for individual cognitive-behavior therapy, supportive-expressive group psychotherapy, and Sertraline for the treatment of depression in multiple sclerosis. Journal of Counseling mid Clinical Psychology, 69(6), 942-949.
40. Mohr, D., & Cox, D. (2001). Multiple sclerosis: Empirical literature for the clinical health psychologist. Journal of Clinical Psychology, 57, 479-499.
41. Mohr, D., & Dick, L. (1998). Multiple sclerosis. In P. M. Camic & S. Knight (Eds.), Clinical handbook of health psychology: A practical guide to effective interventions (pp. 313-348). Seattle, WA: Hogrefe & Huber.
42. Mohr, D., & Goodkin, D. (1999). Treatment of depression in multiple sclerosis: Review and meta-analysis. Clinical Psychology: Science and Practice, 6, 1-9.
43. Mohr, D., Goodkin, D., Gatto, N., & Van der Wende, J. (1997) Depression, coping, and level of neurological impairment in multiple sclerosis. Multiple Sclerosis, 3, 254-258.
44. Mohr, D., Goodkin, D., Likosky, W., Gatto, N., Baumann, K., & Rudick, R. (1997). Treatments of depression improves adherence to Interferon beta I b therapy for multiple sclerosis, Archives of Neurology, 54, 532-533.
45. Mohr, D., Goodkin, D., Likosky, W., Gatto, N., Neilley, L., Griffen, C., & Stiebling, B. (1996). Therapeutic expectations of patients with multiple sclerosis upon initiating Interferon beta-lb: Relationship to adherence to treatment. Multiple Sclerosis, 2, 222-226.
46. Mohr, D., Hart, S., Julian, L., Catledge, C., Homos-Webb, L., Vella, L., & Tasch, E. (2005). Telephone-administered psychotherapy for depression. Archives of General Psychiatry, 62, 1007-1014.
47. Mohr, D., Likosky, W., Bertagnolli, A., Goodkin, D., Van der Wender, J., Dwyer, P., & Dick, L. (2000). Telephone-administered cognitive-behavior therapy for treatment of depressive symptoms in MS. Journal of Consulting and Clinical Psychology, 68(2), 356-361.
48. Muthny, F. (1989). Freiburger Fragebogen zur Krankheitsverarbeitung (FKV). Gottinger: Hogrefe.
49. National Multiple Sclerosis Society. (2000). Consortium of Multiple Sclerosis Centers. Retrieved April 10, 2006, from http://www.MScare.org
50. Noonan, C., Kathman, S., & White, M. (2002). Prevalence estimates for MS in the United States and evidence of an increasing trend for women. Neurology, 58, 136-138.
51. Noseworthy, J., Lucchinetti, C., Rodriguez, M., & Weinshenker, B. (2000). Multiple sclerosis. New England Journal of Medicine, 343, 938-952.
52. Oken, B., Kishiyama, S., Zajdel, D., Bourdette, D., Carlsen, A., Haas, D., Hugos, C., Kraemer, D., Lawrence, J., & Mass, M. (2004). Randomized controlled trial of yoga and exercise in multiple sclerosis. Neurology, 62, 2058-2064.
53. Patten, S., Beck, C., Williams, J., Barbui, C., & Metz, L. (2003). Major depression in multiple sclerosis: A population-based perspective. Neurology, 9(61), 1524-1527.
54. Paty, D., & Ebers, G. (1998). Multiple sclerosis. Philadelphia: F.A. Davis.
55. Potts, M., Daniels, M., Burnam, M., & Wells, K. (1991). A structured interview version of the Hamilton Depression Rating Scale: Evidence of reliability and validity of administration. Journal of Psychiatric research, 24, 335-350.
56. Rao, S., Leo, G., Ellington, L., Nauertz, T., & Bernardin, L. (1991). Cognitive dysfunction in multiple sclerosis II. Impact on employment and social functioning. Neurology, 41, 692-696.
57. Sadovnick, A., Eisen, K., Ebors, G., & Paty, D. (1991). Causes of death in patients attending multiple sclerosis clinics. Neurology, 41, 1193-1196.
58. Sadovnick, A., Remick, R., Allen, J., Swartz, E., Yee, L, Eisen, K., Farquhar, R., Hashimoto, S., Hooge, J., Kastrukoff, L., Morrisone, W., Oger, J., & Patty, D. (1996). Depression and multiple sclerosis. Neurology, 46, 628-632.
59. Schapiro, R. (1994). Symptom management in multiple sclerosis. Annals of Neurology, 36, S123-S129.
60. Schmid, W., & Aldridge, D. (2004). Active music therapy in the treatment of MS patients: A matched control study. Journal of Music Therapy, 4/(3), 225-240.
61. Simon, G., Revicki, D., & Von Korff, M. (1993). Telephone assessment of depression severity. Journal of Psychiatric Research, 27, 247-252.
62. Spielberger, C., Gorsuch, R., & Lushene, R. (1983). The state trait anxiety inventory (STAI) test manual Palo Alto, CA: Consulting Psychologists Press.
63. Spitzer, R., & Willliams, J. (1985). Instruction manual for the Structured Clinical Interview for DSM-111 (SCID). New York: New York State Psychiatric Institute, Biomedical Research Division.
64. Stern, M. (2005). Aging with multiple sclerosis. Physical Medicine Rehabilitation Clinics of North America, 16, 219-234.
65. Taser, N., Baumhackl, U., Kopp, M., & Gunther, V. (2003). Effects of psychological group therapy in patients with MS. Acta Neurologica Scandinavia, 107, 394-399.
66. Thompson, A. (1996) Multiple sclerosis: Symptomatic treatment. Journal of Neurology, 243, 559-565.
67. Thorne, S., McCormick, J., & Carty, E. (1997). Deconstructing the gender neutrality of chronic illness and disability. Health Care for Women International, 18, 1-16.
68. Uccelli, M., Mohr, L., Battaglia, M., Zagami, P., & Mohr, D. (2004). Peer support groups in MS: Current effectiveness and future direction. Multiple Sclerosis, 10, 80-84.
69. Vickrey, B., Hays, R., Harooni, R., Myers, L., & Ellison, G. (1995). A health-related quality of life measure for multiple sclerosis. Quality of Life Research, 4, 187-206.
70. Ware, J. (1993). SF-36Health Survey: Manual interpretation guide. Boston: The Health Institute.
71. Watson, D. (1988). Intraindividual and interindividual analyses of positive and negative affect: Their relation to health complaints, perceived stress and daily activities. Journal of Perspective in Social Psychology, 54, 1020-1030.
72. Weinshenker, B. (1994) The natural history of MS. Annals of Neurology, 36, S6-S11.
73. Weinshenker, B., Bass, B., Rice, G., Noseworthy, J., Carriere, W, Baskerville, J., & Ebers, G. (1989). The natural history of multiple sclerosis: A geographically based study. 2: Predictive value of the early clinical course. Brain, 112, 1419-1428.
74. Weinstock-Guttman, B., Jacobs, L., Brownscheidle, C., Baier, M., & Rea, D. (2003). Multiple sclerosis characteristics in African American patients in the New York State multiple sclerosis consortium. Multiple Sclerosis, 9, 293-298.
75. Zabad, R., Patten, S., & Metz, L. (2005). The association of depression with disease course in multiple sclerosis. Neurology, 64, 359-360.
76. Zigmond, A., & Snaith, R. (1983). The hospital anxiety and depression scale. Acta Psychiatrica Scandinavica, 67, 371-370.